Helicobacter pylori-associated gastritis leads to the development of gastric cancer. Kyoto global consensus report on H. pylori gastritis recommended H. pylori eradication therapy to prevent gastric cancer. To manage H. pylori infection, it is important to choose the appropriate regimen considering regional differences in resistance to clarithromycin and metronidazole. Quinolones and rifabutin-containing regimens are useful as third- and fourth-line rescue therapies.
|Number of pages||8|
|Journal||Journal of gastroenterology|
|Publication status||Published - 2018 Mar 1|
- Gastric cancer
- H. pylori
ASJC Scopus subject areas